4//SEC Filing
CORIXA CORP 4
Accession 0001209191-05-037230
CIK 0001042561operating
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 9:50 PM ET
Size
10.5 KB
Accession
0001209191-05-037230
Insider Transaction Report
Form 4
CORIXA CORPCRXA
GLAXOSMITHKLINE PLC
10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2005-07-12$4.40/sh−57,515,477$253,068,099→ 0 total - Purchase
Series A Preferred Stock, par value $0.001 per share
2005-07-12$517.65/sh−12,500$6,470,625→ 0 total - Purchase
Series B Preferred Stock, par value $0.001 per share
2005-07-12$172.01/sh−37,500$6,450,375→ 0 total
SMITHKLINE BEECHAM CORP
10% Owner
Transactions
- Purchase
Series B Preferred Stock, par value $0.001 per share
2005-07-12$172.01/sh−37,500$6,450,375→ 0 total - Purchase
Common Stock, par value $0.001 per share
2005-07-12$4.40/sh−57,515,477$253,068,099→ 0 total - Purchase
Series A Preferred Stock, par value $0.001 per share
2005-07-12$517.65/sh−12,500$6,470,625→ 0 total
Footnotes (1)
- [F1]All of the outstanding stock of Corixa Corporation was canceled in a merger of Corixa Corporation with GSK Delaware Corp., a wholly owned subsidiary of SmithKline Beecham Corporation, on July 12, 2005 pursuant to the Agreement and Plan of Merger, dated as of April 29, 2005, by and among SmithKline Beecham Corporation, GSK Delaware Corp. and Corixa Corporation.
Documents
Issuer
CORIXA CORP
CIK 0001042561
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042561
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 9:50 PM ET
- Size
- 10.5 KB